Search Results - Yasuhiro Gon

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Corrigendum to “Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial” [Allergol Int 74 (2025) 274-82]

    Corrigendum to “Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial” [Allergol Int 74 (2025) 274-82] by Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, Norihiro Harada, Yasunari Miyazaki, Hideki Katsura, Etsuko Tagaya, Junko Terada, Masayuki Hojo, Naoya Sugimoto, Hiroyuki Nagase, Yuta Kono, Hisato Hiranuma, Yasuhiro Gon, Ryo Takemura, Misato Irie, Reina Nakamura, Hiroki Kabata, Jun Miyata, Koichi Fukunaga

    Published 2025-07-01 Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction

    Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction by Toshihiro Shirai, Keita Hirai, Taisuke Akamatsu, Kenji Mizumura, Hitoshi Sasano, Norihiro Harada, Akihiko Tanaka, Hironori Sagara, Katsunori Masaki, Koichi Fukunaga, Konomi Kobayashi, Hiroyuki Nagase, Nobuaki Miyahara, Arihiko Kanehiro, Noboru Kitamura, Naruhiko Sugihara, Junko Terada-Hirashima, Masayuki Hojo, Kazuyuki Chibana, Etsuko Tagaya, Yasuhiro Gon

    Published 2025-07-01 Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)

    Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo) by Hiroyuki Nagase, Konomi Kobayashi, Makiko Toma-Hirano, Maho Suzukawa, Norihiro Harada, Katsunori Masaki, Yoshito Miyata, Mayoko Tsuji, Junko Terada-Hirashima, Keiko Komatsuzaki, Hitoshi Sasano, Kenji Mizumura, Ryoji Kagoya, Yuya Shimizu, Shintaro Yoshihara, Norio Kihara, Yasunari Miyazaki, Toshiyuki Koya, Naruhiko Sugihara, Nobuhisa Ishikawa, Masayuki Hojo, Etsuko Tagaya, Akihiko Tanaka, Koichi Fukunaga, Yasuhiro Gon

    Published 2025-07-01

    Background: Although randomized controlled trials (RCT) have demonstrated the efficacy of mepolizumab for asthma, they have excluded certain patient subgroups. To bridge the gap between RCT and real-world practice, the effectiveness of mepolizumab in a diverse population, including those potentially...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: